featured
Direct Oral Anticoagulants vs Low–Molecular-Weight Heparin for Preventing Recurrent Venous Thromboembolism in Patients With Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial
JAMA 2023 Jun 02;[EPub Ahead of Print], D Schrag, H Uno, R Rosovsky, C Rutherford, K Sanfilippo, JL Villano, M Drescher, N Jayaram, C Holmes, L Feldman, O Zattra, H Farrar-Muir, C Cronin, E Basch, A Weiss, JM ConnorsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.